Endo International plc (ENDP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 ENDO BOULEVARD CHADDS FORD, PA 19317

Develops and markets a portfolio of branded and generic pharmaceutical products primarily for the treatment of pain, including Percocet and Percodan. The company's products are marketed primarily to wholesale drug distributors and chain and independent retail pharmacists.

Data based on most recent fiscal year report
Market Cap1.447 Billion Shares Outstanding226.78 Million Avg Volume7.856 Million
1-Yr BETA vs S&P TR1.657 Current Ratio1.2 Quick Ratio1.04
View SEC Filings from ENDP instead.

View recent insider trading info

Funds Holding ENDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ENDP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SMITH JILL D.

0 2020-01-15 0

LAVISCOUNT JOYCE N CFO AND COO

  • Officer
37,569 2020-01-15 0

MEANWELL CLIVE CHIEF INNOVATION OFFICER

  • Officer
  • Director
0 2020-01-06 0

CIAFFONI JOSEPH PRESIDENT AND CEO

  • Officer
  • Director
171,686 2020-01-02 0

ROWLAND CHARLES A JR

  • Director
0 2020-01-02 0

HIGGINS ARTHUR J

  • Director
19,070 2019-12-31 0

MALETTA MATTHEW JOSEPH EVP, CHIEF LEGAL OFFICER

  • Officer
106,831 2019-12-31 7

INGRAM DOUGLAS S PRESIDENT & CEO

  • Officer
  • Director
395,012 2019-12-31 0

SCODARI JOSEPH C

  • Director
12,530 2019-12-06 0

HUTSON NANCY J

  • Director
56,554 2019-12-01 1

BARRY PATRICK A EVP & CHIEF COMMERCIAL OFFICER

  • Officer
48,327 2019-12-01 5

WYSENSKI NANCY

  • Director
0 2019-11-12 0

LEVIN ALAN G

  • Director
0 2019-10-01 0

NICHOL CARRIE ANN VP, CONTROLLER & CAO

  • Officer
0 2019-10-01 6

GARELLA RAHUL EVP, INTL PHARMACEUTICALS

  • Officer
28,495 2019-10-01 3

CAMPANELLI PAUL PRESIDENT, CEO

  • Officer
  • Director
675,829 2019-09-28 6

COUGHLIN TERRANCE J EVP, CHIEF OPERATING OFFICER

  • Officer
246,459 2019-09-28 6

BOYLE JACK D. SVP, INTERIM CONTROLLER

  • Officer
71,347 2019-09-27 1

KIMMEL ROGER H

  • Director
203,309 2019-09-16 3

CIARICO DOMENICO EVP & CHIEF COMMERCIAL OFFICER

  • Officer
197,596 2019-09-03 2

DEGOLYER DONALD W

  • Director
0 2019-08-22 0

COLEMAN BLAISE EVP, CHIEF FINANCIAL OFFICER

  • Officer
110,124 2019-08-10 6

UPADHYAY SUKETU EXEC. VP, CFO

  • Officer
0 2019-07-01 0

MONTAGUE WILLIAM P

  • Director
92,871 2019-06-12 1

HYATT MICHAEL

  • Director
317,373 2019-06-12 1

COOKE SHANE

  • Director
82,074 2019-06-12 1

MANSUKANI SHARAD

  • Director
71,523 2019-06-12 1

MCHUGH JULIE

  • Director
109,337 2019-06-05 0

NASH DAVID

  • Director
5,236 2019-05-24 0

PERA ANTONIO R PRESIDENT, PAR PHARMACEUTICAL

  • Officer
65,648 2019-04-02 4

GERGEL IVAN P.

  • Director
0 2019-03-15 0

FARHAT CAMILLE CHIEF EXECUTIVE OFFICER

  • Officer
0 2019-03-08 0

SISITSKY TODD BENJAMIN

  • Director
0 2018-10-10 0

RUDIO DANIEL SVP, CONTROLLER

  • Officer
9,669 2018-02-23 0

SWEENEY EDWARD J INTERIM CFO

  • Officer
0 2017-06-01 0

VARGHESE HEMANTH JACOB PRES. INTERNATIONAL PHARMA

  • Officer
4,350 2016-04-29 0

DE SILVA RAJIV PRESIDENT & CEO

  • Officer
  • Director
355,010 2016-03-18 0

SPENGLER WILLIAM

  • Director
48,835 2016-03-17 0

HALL SUSAN EVP, CSO, GLOBAL HEAD OF R&D

  • Officer
4,826 2016-03-11 0

LORTIE BRIAN PRESIDENT BRANDED PHARMA

  • Officer
24,504 2016-03-02 0

MANOGUE CAROLINE B EXEC. V.P.,CHIEF LEGAL OFFICER

  • Officer
43,100 2015-04-07 0

DELUCCA JOHN

  • Director
32,343 2015-03-04 0

HOLVECK DAVID PRESIDENT & CEO

  • Officer
  • Director
29,528 2013-02-26 0

D. E. SHAW VALENCE PORTFOLIOS, L.L.C.

D. E. SHAW & CO, L.P.

SHAW DAVID E

  • 10% Owner
  • SEE FOOTNOTE 4.SEE FOOTNOTE 4.SEE FOOTNOTE 4.
No longer subject to file 2009-03-05 0

DE ROSEN MICHEL

  • Director
137,100 2008-11-07 0

HORNER GEORGE F III

  • Director
5,003 2008-03-12 0

LEE DAVID A H EXEC. V.P AND CSO

  • Officer
2,801 2008-02-21 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MALETTA MATTHEW JOSEPH - Officer EVP, CHIEF LEGAL OFFICER

2019-12-31 F 598 $4.59 d 106,831 106,831.00 direct

BARRY PATRICK A - Officer EVP & CHIEF COMMERCIAL OFFICER

2019-12-01 F 2,619 $4.95 d 48,327 48,327.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments